vs
Enact Holdings, Inc.(ACT)与AdvanSix Inc.(ASIX)财务数据对比。点击上方公司名可切换其他公司
AdvanSix Inc.的季度营收约是Enact Holdings, Inc.的1.2倍($359.9M vs $312.7M),AdvanSix Inc.同比增速更快(9.4% vs 3.6%),过去两年Enact Holdings, Inc.的营收复合增速更高(3.6% vs 3.4%)
Enact Holdings, Inc.是美国领先的私人抵押贷款保险服务商,为银行、信用社等各类住宅抵押贷款机构提供风险缓释解决方案,帮助首付较低的购房者获得可负担的住房贷款,助力更多美国普通消费者实现安居需求。
AdvanSix Inc.是一家美国化工企业,主营尼龙6以及己内酰胺、硫酸铵肥料等相关化工产品。该公司原为霍尼韦尔旗下树脂与化工事业部,于2016年分拆独立,2019年预估营收达14亿美元,其企业历史可追溯至1884年在宾夕法尼亚州法兰克福成立的H. W. Jayne公司。
ACT vs ASIX — 直观对比
营收规模更大
ASIX
是对方的1.2倍
$312.7M
营收增速更快
ASIX
高出5.8%
3.6%
两年增速更快
ACT
近两年复合增速
3.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $312.7M | $359.9M |
| 净利润 | — | $-2.8M |
| 毛利率 | — | 7.6% |
| 营业利润率 | 71.3% | -0.7% |
| 净利率 | — | -0.8% |
| 营收同比 | 3.6% | 9.4% |
| 净利润同比 | — | -892.9% |
| 每股收益(稀释后) | $1.23 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ACT
ASIX
| Q4 25 | $312.7M | $359.9M | ||
| Q3 25 | $311.5M | $374.5M | ||
| Q2 25 | $304.9M | $410.0M | ||
| Q1 25 | $306.8M | $377.8M | ||
| Q4 24 | $301.8M | $329.1M | ||
| Q3 24 | $309.6M | $398.2M | ||
| Q2 24 | $298.8M | $453.5M | ||
| Q1 24 | $291.6M | $336.8M |
净利润
ACT
ASIX
| Q4 25 | — | $-2.8M | ||
| Q3 25 | — | $-2.6M | ||
| Q2 25 | — | $31.4M | ||
| Q1 25 | — | $23.3M | ||
| Q4 24 | — | $352.0K | ||
| Q3 24 | — | $22.3M | ||
| Q2 24 | — | $38.9M | ||
| Q1 24 | — | $-17.4M |
毛利率
ACT
ASIX
| Q4 25 | — | 7.6% | ||
| Q3 25 | — | 6.8% | ||
| Q2 25 | — | 14.3% | ||
| Q1 25 | — | 14.2% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | — | 17.9% | ||
| Q1 24 | — | 0.9% |
营业利润率
ACT
ASIX
| Q4 25 | 71.3% | -0.7% | ||
| Q3 25 | 67.4% | -0.9% | ||
| Q2 25 | 70.4% | 7.7% | ||
| Q1 25 | 68.9% | 7.7% | ||
| Q4 24 | 68.9% | -3.9% | ||
| Q3 24 | 74.1% | 7.5% | ||
| Q2 24 | 78.6% | 11.5% | ||
| Q1 24 | 70.6% | -7.0% |
净利率
ACT
ASIX
| Q4 25 | — | -0.8% | ||
| Q3 25 | — | -0.7% | ||
| Q2 25 | — | 7.7% | ||
| Q1 25 | — | 6.2% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 5.6% | ||
| Q2 24 | — | 8.6% | ||
| Q1 24 | — | -5.2% |
每股收益(稀释后)
ACT
ASIX
| Q4 25 | $1.23 | $-0.11 | ||
| Q3 25 | $1.10 | $-0.10 | ||
| Q2 25 | $1.11 | $1.15 | ||
| Q1 25 | $1.08 | $0.86 | ||
| Q4 24 | $1.05 | $0.02 | ||
| Q3 24 | $1.15 | $0.82 | ||
| Q2 24 | $1.16 | $1.43 | ||
| Q1 24 | $1.01 | $-0.65 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $582.5M | $19.8M |
| 总债务越低越好 | $744.5M | — |
| 股东权益账面价值 | $5.4B | $815.2M |
| 总资产 | $6.9B | $1.7B |
| 负债/权益比越低杠杆越低 | 0.14× | — |
8季度趋势,按日历期对齐
现金及短期投资
ACT
ASIX
| Q4 25 | $582.5M | $19.8M | ||
| Q3 25 | $545.6M | $23.7M | ||
| Q2 25 | $616.0M | $18.4M | ||
| Q1 25 | $639.0M | $8.3M | ||
| Q4 24 | $602.8M | $19.6M | ||
| Q3 24 | $674.9M | $17.3M | ||
| Q2 24 | $711.3M | $12.1M | ||
| Q1 24 | $624.3M | $20.6M |
总债务
ACT
ASIX
| Q4 25 | $744.5M | — | ||
| Q3 25 | $744.1M | — | ||
| Q2 25 | $743.8M | — | ||
| Q1 25 | $743.4M | — | ||
| Q4 24 | $743.0M | — | ||
| Q3 24 | $742.7M | — | ||
| Q2 24 | $742.4M | — | ||
| Q1 24 | $746.1M | — |
股东权益
ACT
ASIX
| Q4 25 | $5.4B | $815.2M | ||
| Q3 25 | $5.3B | $818.2M | ||
| Q2 25 | $5.2B | $823.7M | ||
| Q1 25 | $5.1B | $794.4M | ||
| Q4 24 | $5.0B | $774.6M | ||
| Q3 24 | $5.0B | $766.4M | ||
| Q2 24 | $4.8B | $746.6M | ||
| Q1 24 | $4.7B | $713.2M |
总资产
ACT
ASIX
| Q4 25 | $6.9B | $1.7B | ||
| Q3 25 | $6.9B | $1.7B | ||
| Q2 25 | $6.8B | $1.6B | ||
| Q1 25 | $6.7B | $1.6B | ||
| Q4 24 | $6.5B | $1.6B | ||
| Q3 24 | $6.6B | $1.5B | ||
| Q2 24 | $6.3B | $1.5B | ||
| Q1 24 | $6.3B | $1.5B |
负债/权益比
ACT
ASIX
| Q4 25 | 0.14× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.14× | — | ||
| Q1 25 | 0.15× | — | ||
| Q4 24 | 0.15× | — | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | 0.16× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $724.5M | $63.7M |
| 自由现金流经营现金流 - 资本支出 | — | $36.1M |
| 自由现金流率自由现金流/营收 | — | 10.0% |
| 资本支出强度资本支出/营收 | — | 7.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $6.4M |
8季度趋势,按日历期对齐
经营现金流
ACT
ASIX
| Q4 25 | $724.5M | $63.7M | ||
| Q3 25 | $192.0M | $26.6M | ||
| Q2 25 | $119.5M | $21.1M | ||
| Q1 25 | $226.7M | $11.4M | ||
| Q4 24 | $686.3M | $64.2M | ||
| Q3 24 | $188.1M | $57.3M | ||
| Q2 24 | $144.7M | $50.2M | ||
| Q1 24 | $187.3M | $-36.2M |
自由现金流
ACT
ASIX
| Q4 25 | — | $36.1M | ||
| Q3 25 | — | $66.0K | ||
| Q2 25 | — | $-7.2M | ||
| Q1 25 | — | $-22.6M | ||
| Q4 24 | — | $29.8M | ||
| Q3 24 | — | $26.8M | ||
| Q2 24 | — | $16.7M | ||
| Q1 24 | — | $-71.6M |
自由现金流率
ACT
ASIX
| Q4 25 | — | 10.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | -1.7% | ||
| Q1 25 | — | -6.0% | ||
| Q4 24 | — | 9.1% | ||
| Q3 24 | — | 6.7% | ||
| Q2 24 | — | 3.7% | ||
| Q1 24 | — | -21.3% |
资本支出强度
ACT
ASIX
| Q4 25 | — | 7.7% | ||
| Q3 25 | — | 7.1% | ||
| Q2 25 | — | 6.9% | ||
| Q1 25 | — | 9.0% | ||
| Q4 24 | — | 10.4% | ||
| Q3 24 | — | 7.7% | ||
| Q2 24 | — | 7.4% | ||
| Q1 24 | — | 10.5% |
现金转化率
ACT
ASIX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.67× | ||
| Q1 25 | — | 0.49× | ||
| Q4 24 | — | 182.29× | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 1.29× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACT
暂无分部数据
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |